Metraipolis › archive › dc_892270444ebb

Impact of cilostazol on clinical outcomes in lower extremity arterial disease patients after angioplasty: A real-world analysis — Europe PMC PMID:40839648

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40839648
DOI
10.1371/journal.pone.0330434
License (as archived)
solo-consultazione
Archived
2026-11-10T11:09:08.940Z
SHA-256 of the archived text
4f4893f1fbc9e35d2e76b1747c81edd58c24bd7e1d160475468e80a7520a1b88
Stable URL of this page
https://metraipolis.com/documento/dc_892270444ebb

How to cite

Impact of cilostazol on clinical outcomes in lower extremity arterial disease patients after angioplasty: A real-world analysis — Europe PMC PMID:40839648 — Europe PMC (en), https://europepmc.org/article/MED/40839648 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_892270444ebb (Metraipolis archive dc_892270444ebb, sha256 4f4893f1fbc9e35d2e76b1747c81edd58c24bd7e1d160475468e80a7520a1b88)
BibTeX
@misc{dc892270444ebb,
  title = {Impact of cilostazol on clinical outcomes in lower extremity arterial disease patients after angioplasty: A real-world analysis — Europe PMC PMID:40839648},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40839648},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_892270444ebb; sha256 4f4893f1fbc9e35d2e76b1747c81edd58c24bd7e1d160475468e80a7520a1b88},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40839648. Agents can read the archived copy with the MCP tool read_document.